Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by tcdrugson May 05, 2010 3:05pm
424 Views
Post# 17066320

RE: RE: fda approval rates

RE: RE: fda approval ratesI wasn't trying to make any assumptions or predictions based on the article.  I am just trying to get an idea of first cycle approval rates for drugs with priority review as compared with non-priority drugs.  It does seem to be significantly higher regardless of company size.  Everything I have seen so far from LUX has given me a lot of  confidence that they know what they are doing and will have every i dotted and t crossed in their application. 
<< Previous
Bullboard Posts
Next >>